Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of the South Carolina Medical Association (1975)
|
July 4, 2001
Spontaneous renal artery dissection in a healthy man
J C Boughey, R R Gifford, J B Collins, et al.
The American Surgeon
|
February 18, 2004
Chloride/phosphate ratio in primary hyperparathyroidism
J C Boughey, C J Ewart, M J Yost, et al.
The British Journal of Surgery
|
February 15, 2020
Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database
A R Kupstas, T L Hoskin, C N Day, et al.
Breast Cancer Research : BCR
|
June 23, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
Roberto A Leon-Ferre, K Dimitroff, C Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial
R Lesurf, O L Griffith, M Griffith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2022
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials
M Marczyk, A Mrukwa, C Yau, et al.
Annals of Surgical Oncology
|
August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
M Kaur, K Dimitroff, J C Boughey, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of the South Carolina Medical Association (1975)
|
July 4, 2001
Spontaneous renal artery dissection in a healthy man
J C Boughey, R R Gifford, J B Collins, et al.
The American Surgeon
|
February 18, 2004
Chloride/phosphate ratio in primary hyperparathyroidism
J C Boughey, C J Ewart, M J Yost, et al.
The British Journal of Surgery
|
February 15, 2020
Biological subtype, treatment response and outcomes in inflammatory breast cancer using data from the National Cancer Database
A R Kupstas, T L Hoskin, C N Day, et al.
Breast Cancer Research : BCR
|
June 23, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
Roberto A Leon-Ferre, K Dimitroff, C Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial
R Lesurf, O L Griffith, M Griffith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2022
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials
M Marczyk, A Mrukwa, C Yau, et al.
Annals of Surgical Oncology
|
August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
M Kaur, K Dimitroff, J C Boughey, et al.
Page
of 1